The ACCELERATE trial found no RFS improvement with chemoradiation addition in resected gallbladder cancer patients. Median survival was 52.7 months, with more deaths in the CRT plus chemotherapy arm.

Results from the phase 3 ACCELERATE trial (CTRI/2018/04/013218), presented at the 2025 ASCO Gastrointestinal Symposium, showed no improvement in relapse-free survival (RFS) with the addition of ...

The Biggest Risk Factor for Bladder Cancer Has Nothing to Do With Pee, Diet, or Genes 1. Virani NA, Davis C, McKernan P, Hauser P, Hurst RE, Slaton J, Silvy RP, Resasco DE, Harrison RG.

Because thickening of the gallbladder wall is observed not only in patients with gallbladder cancer but also in those with benign diseases such as chronic cholecystitis and gallbladder adenomyosis ...

The face of cancer in the U.S. is getting younger—and more feminine. Cancer rates for women in the U.S. have risen over the past half-century, particularly among women under age 65 diagnosed ...

SINGAPORE – A combination of two existing chemotherapy drugs has been used to fight bladder cancer successfully for the first time in Singapore. This new union of the two “off-label” drugs ...

The gallbladder is a small organ that plays a vital role in digesting the foods you eat. You may need to follow a gallbladder diet if you have gallstones or if your gallbladder is inflamed or infected ...

Researchers discover novel targets for bladder cancer therapeutics and demonstrate that a new combination of existing drugs, including statins, blocks tumor growth in mice. Like all cancers ...

Like all cancers, bladder cancer develops when abnormal cells start to multiply out of control. But what if we could put a lid on their growth? Previous studies showed that a protein called PIN1 ...

No children in this study presented with jaundice symptoms. Laboratory tests showed an elevated white blood cell count. Imaging characteristics included thickening of the gallbladder wall, gallbladder ...

Pfizer's Bladder Cancer Therapy Meets Main Goal in Late-Stage Study (Reuters) -Pfizer's experimental treatment for a type of bladder cancer significantly improved the time that patients remained ...

Jan 10 (Reuters) - Pfizer's (PFE.N), opens new tab experimental treatment for a type of bladder cancer significantly ... 3:42 PM UTC · Updated ago category Wall St slides as Trump's tariffs ...